1. In healthy volunteers plasma concentrations of immunoreactive substance P were measured in response to changes in posture and dietary salt intake.
Introduction
Substance P, an undecapeptide (Chang & Leeman, 1970; Studer, Trzeciak & Lergier, 1973) originally isolated from brain and intestine (von Correspondence: Professor H. J. Kramer, Professor of Medicine, Medizinische Universitats-Poliklinik, Wilhelmstrasse 35-37,5300 Bonn l, F.R.G. Euler & Gaddum, 1931) , is present in hypothalamic tissue of various species (Powell, Leeman, Tregear, Niall & Potts, 1973) and is found in high concentrations in the pituitary gland (Yanaihara, Sato, Hirohashi, Sakagami, Yamamoto, Hashimoto, Yanaihara, Aba & Kaneko, 1976) . Experimental data suggest that this neurotransmitter may play a role in the regulation of water balance (de Caro, Massi & Micossi, 1978; Strumillo-Dyba, 1978; Gullner, Campbell & Pettinger, 1979) and may also participate in the control of renin release (Gullner & Bartter, 1979) . At low concentrations, substance P increases blood flow and lowers arterial blood pressure (Fisher, Humphries & Folkers, 1974) and is a potent natriuretic peptide when infused into the renal artery (Macfarlane, Mills & Ward, 1974) or systemically into the jugular vein (Flachskampf, Dusing & Kramer, 1980) . This natriuresis appears to result predominantly from decreased proximal-tubular sodium absorption (Arendshorst, Cook & Mills, 1976; Flachskampf et al., 1980) . However, at present there is little information on the plasma concentrations of substance P in man (Nilsson, Pernow, Fisher & Folkers, 1975; Yanaihara et al., 1976) and no data concerning its response to physiological stimuli have been reported so far. This study was therefore undertaken to investigate immunoreactive substance P in human plasma under physiological conditions, i.e. its diurnal variation and response to changes in posture and dietary salt intake.
Materials and methods
Plasma concentrations of immunoreactive substance P were determined in 14 healthy volunteers (seven female and seven male subjects, aged 19-35 years) at 08.00 hours after an overnight fast, in the supine position, on the next morning at 08.00 hours after 2 h of upright posture and again at 11.00 hours when they were ambulant. In addition, in five healthy male subjects plasma concentrations of immunoreactive substance P were determined at 6 h intervals, with subjects supine for 24 h.
In eight subjects plasma concentrations of immunoreactive substance P were measured after an overnight fast at 08.00 hours during sodium intake ad lib., on day 4 of sodium restriction (35 mmol/day) and again on day 4 of high sodium intake (350 mmol/day).
Blood was collected without tourniquet from the antecubital vein into plastic tubes containing phenanthroline and EDTA. After centrifugation, plasma was deproteinized with ethanol, acidified with hydrochloric acid (10 mmol/l) and extracted with methylene chloride. The aqueous phase was then freeze-dried and dissolved in bovine serum albumin/peptone buffer before assay. Mean recovery of added 1251-labelled substance P was 43 f 2%. Radioimmunoassay of substance P was performed with a rabbit anti-substance P antiserum and 1Z51-labelled substance P (Immuno Nuclear Corporation, Stillwater, Minnesota, U.S.A.). This antibody cross-reacts with other neurotransmitters as follows: methionineenkephalin, leucine-enkephalin, eledoisin and physalaemin <0.002%; /-?-endorphin 0.008%. Unlabelled substance P was purchased from Serva GmbH, Heidelberg, F.R.G.
Mean binding of lz5I-labelled substance P to the antibody was 60.3 f 1.7% and the lower detection limit of the assay was 14 pmol/l. Of 300 pmol of substance P added to plasma with known amounts of immunoreactive substance P, 86-108% was recovered. Serial dilutions of plasma were assayed and were found to parallel the standard curve. When identical samples were assayed repeatedly the intra-assay variability was +8.5% and the coefficient of variation of the interassay variability was 9.8%. All determinations were performed in duplicate. Results were corrected for recovery and expressed as pmol/l. Statistical analysis was performed with a paired Student's t-test and results are expressed as means f SEM.
Results
In 14 subjects supine plasma concentrations of immunoreactive substance P at 08. reported by Nilsson et al. (1975) and Yanaihara et al. (1976) . Mean plasma concentration of immunoreactive substance P in these subjects after 2 h of ambulation at 08.00 hours was 401 + 51 pmol/l ( Fig. la) and after 3 h of ambulation at 11.00 hours was 378 f 29 pmol/l (P < 0.001). In five additional subjects a diurnal variation of supine plasma immunoreactive substance P was observed: mean plasma concentration at 08.00 hours was 129 f 18 pmol/l and rose to a value of 240 f 39 pmol/l at 14.00 hours (P < 0.05). It declined to 156 k 18 pmol/l at 20.00 hours and to 76 f 9 pmol/l at 2.00 hours (P < 0.01 as compared with values at 08.00 hours. At 08.00 hours mean plasma concentration again returned to 162 & 25 pmol/l. On day 4 of low salt intake, no significant changes in the concentration of immunoreactive substance P in plasma of eight subjects were observed (244 f 45 vs 169 f 41 pmol/l on sodium intake ad lib.), and it decreased significantly after 4 days on a high salt intake (5 1 f 20 pmol/l; P < 0.001) (Fig. lb) .
Discussion
Although substance P is a potent natriuretic peptide when infused systemically (Flachskampf et al., 1980) or into the renal artery of the rat (Arendshorst et al., 1976) , the present results do not favour a role of endogenous substance P as a circulating natriuretic factor in man under the present experimental conditions.
